Moffitt Cancer Center What is the best part of working at the company? My co-workers and the physician and nurses were extraordinary. What is the most stressful part about working at the company? I had multiple people I worked for and they all had different answers and...显示更多 ...
When “an immunologically effective amount”, “an anti-tumor effective amount”, “an tumor-inhibiting effective amount”, or “therapeutic amount” is indicated, the precise amount of the compositions of the present invention to be administered can be determined by a physician with consideration of...
Export Citation: Click for automatic bibliography generation Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. International Classes: G16H50/50;G16H10/60;G16H50/20 View Patent Images: Download PDF 20210174970 US Patent References: Attorney, Agent or Firm: Meunier Carlin & Cur...
When “an immunologically effective amount”, “an anti-tumor effective amount”, “an tumor-inhibiting effective amount”, or “therapeutic amount” is indicated, the precise amount of the compositions of the present invention to be administered can be determined by a physician with consideration of...
primate, bovine, equine, porcine, canine, or feline. The subject can also be a guinea pig, rat, hamster, rabbit, mouse, or mole. Thus, the subject can be a human or veterinary patient. The term “patient” refers to a subject under the treatment of a clinician, e.g., physician. ...
The term “patient” refers to a subject under the treatment of a clinician, e.g., physician. The term “sample from a subject” refers to a tissue (e.g., tissue biopsy), organ, cell (including a cell maintained in culture), cell lysate (or lysate fraction), biomolecule derived from...
(RT) efficacy using the patient genomic information and estimate likelihood of response to RT of an individual patient. Later, the results of this model will be implemented into a decision model with the objective of guiding the patient and physician decision on the selection of a cancer ...